Drug intelligence / Profile preview

Refresh Optive Advanced

Development stage
Unknown
Lead developer
Allergan
Administration
Ophthalmic
01

Overview

**Refresh Optive Advanced** is a lipid-containing, triple-action artificial-tear ophthalmic formulation developed by Allergan and subsequently managed within AbbVie. It contains carboxymethylcellulose sodium 0.5%, glycerin 1%, and polysorbate 80 0.5% as ocular lubricants, with castor oil as an inactive lipid component. The formulation lubricates and hydrates the ocular surface while supporting the tear-film lipid layer to reduce evaporative tear loss. ADV2 was evaluated in the completed randomized NCT01010282 dry-eye study, where it was noninferior to an existing lipid-based artificial tear for dryness symptoms and showed the greatest improvements among tested treatments in tear break-up time and Ocular Surface Disease Index score. ([sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S0149291815000090))

Brand names
Refresh Optive AdvancedRefresh Optive Avancé

Beyond the preview

Go deeper on Refresh Optive Advanced.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Refresh Optive Advanced.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call